| Acute Kidney Injury: New Biomarkers |
|
Sik Lee |
|
Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea |
| 급성 신손상: 새로운 바이오마커 |
|
이식 |
|
전북대학교 의학전문대학원 내과학교실 |
Correspondence:
Sik Lee, Tel: +82-63-250-2151, Fax: +82-63-254-1609, Email: kidney@jbnu.ac.kr
|
|
|
|
|
| This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| Abstract |
|
Acute kidney injury (AKI) has various triggers, such as ischemia, nephrotoxins, radiocontrast, and bacterial endotoxins. It occurs in about one-third of patients treated in the intensive care unit. There is a higher mortality in patients with AKI compared with their non-AKI counterparts. The diagnosis of AKI usually depends on serum creatinine (SCr) measurements. However, SCr is a delayed and unreliable indicator of AKI. The lack of early biomarkers has limited the ability to manage AKI. Fortunately, understanding the early stress response of the kidney to injury has resulted in the identification and validation of several potential novel urine and blood biomarkers. Recently, new biomarkers of AKI with more favorable characteristics than SCr have been identified and studied in various experimental and clinical settings. This article reviews the most well-established biomarkers of AKI. |
| Key Words:
Acute kidney injury; Biomarkers |
| 주제어:
급성 신손상; 바이오마커 |
|
PDF Links
Full text via DOI
Download Citation
